Q2 2021 Santhera Pharmaceuticals Holding AG Earnings Call Transcript
Ladies and gentlemen, welcome to the Santhera Financing and Preliminary First Half Year 2021 Results Conference Call. I am Alice, the Chorus Call operator. (Operator Instructions) The conference must not be recorded for publication or broadcast.
This conference call may contain certain forward-looking statements based on current assumptions and forecasts made by Santhera Pharmaceuticals. Such statements involve certain risks, uncertainties and other factors, which could cause the actual results, financial condition, performance or achievements of Santhera Pharmaceuticals to be materially different from those expressed or implied by such statements. These factors include those discussed in the comprehensive risk factor disclosure on the company's website at www.santhera.com. Santhera disclaims any obligation to update any forward-looking statements.
The conference may be downloaded on Santhera's website during the 2 weeks following the call.
At this time, it's my pleasure to hand over to Mr. Dario Eklund, CEO.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |